Pérez-Revuelta, B I <br/><br/>
Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation.  [electronic resource] 

 -  Cell death & disease  May 2014 
 - e1209 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-4889 
<br/><br/><label>Standard No.: </label>10.1038/cddis.2014.175  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AMP-Activated Protein Kinases--metabolism<br/>Animals<br/>Dose-Response Relationship, Drug<br/>Down-Regulation<br/>Enzyme Activation<br/>Gestational Age<br/>HeLa Cells<br/>Hippocampus--drug effects<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Metformin--pharmacology<br/>Mice<br/>Mice, Inbred C57BL<br/>Neurons--drug effects<br/>Phosphorylation<br/>Primary Cell Culture<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Phosphatase 2--metabolism<br/>Serine<br/>Signal Transduction--drug effects<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Time Factors<br/>Transfection<br/>alpha-Synuclein--genetics